• Date: September 07, 2018

The development of a diagnostic kit for patients with septicaemia and septic shock, a coating bacterial repellent to reduce hospital-acquired infections and new therapeutic treatments against different types of cancer are examples of some of the 20 biomedical research projects that feature in the 2018 edition of CaixaImpulse. All the selected projects can be found by following this link.

In comparison to the previous edition, this year there has been a 6% increase in the participation rate, up to a total of 85 candidates. After a selection process following European standards, 20 projects have been chosen to benefit from the programme. The majority (60%) come from research centres, universities and hospitals in Catalonia, although projects from Madrid, Valencia and Andalusia are also taking part, as well as initiatives from Porto (Portugal). This infographic provides further details.

Since its launch in 2015, CaixaImpulse has allocated 7.5 million euros to 58 projects. Over this time, more than 400 hours of training have been offered, and more than 300 personal meetings have been held between participants and potential associates or investors. The result is that they have already created ten spin-off projects, with seven more in the pipeline.

More programme highlights

February 14, 2019

GlyCardial Diagnostics wins Horizon 2020 funding

Apo J-Glyc, a project selected in CaixaImpulse 2015, is now operating as a company named GlyCardial Diagnostics.

February 12, 2019

“The entrepreneur is the one who has to choose, whether they get it right or make mistakes”

Roger Gomis from IRB talks to us about what CaixaImpulse means to him and explains more about his role as mentor.

February 04, 2019

Applications open for CaixaImpulse’s 2019 call

CaixaImpulse is seeking 25 innovative health and biomedical projects to support and develop starting in 2019.